← pool

📈 COVID vaccine reckoning collapses trust in vaccination

The mRNA COVID vaccines' failure to stop transmission, their two-month efficacy window and the emerging myocarditis safety signal turn into a credibility scandal for Pfizer/Moderna and for public-health authority generally. All four besties say on the record they will never be boosted again, Sacks calls for a distrust spillover onto routine vaccination and Chamath wants a commission to reopen the whole file. The tradeable read-through is a shrinking booster franchise plus reputational, litigation and inquiry overhang on the mRNA makers.

0 CONVICTION
peaked 66.1 GREEN
EMBER
band
▼ SHORT PFE
expression · bearish equities
HIT
outcome · R +34.0% · α +12.1%
2024-01-27
window closed

⚖ Why this verdict

fully deterministic — evaluate.py replays this from daily closes; nothing below is editable or hand-set

  1. Window: 2023-01-27 → 2024-01-27 — first mention + 12-month horizon, then the window locks.
  2. The call: ▼ SHORT PFE (primary play). PFE fell 34.0% over the window → direction-adjusted R = +34.0% (the call made money).
  3. Benchmark: holding SPY over the same window returned +22.0%α = +34.0 − (+22.0) = +12.1% — what this call made or lost against just owning the index. This is the number the verdict uses.
    Stock-selection read: +56.0% — did PFE move the predicted way relative to the market. The two only differ on a SHORT: this call was right about direction relative to the index but still cost money versus holding it.
  4. Rule fired:
    ▶ HIT — R ≥ +10% AND α ≥ +5 ✓ (R 34.0, α 12.1)
    · PARTIAL — R ≥ +5% OR α ≥ 0
    · MISS — everything else
  5. Credit: supporters of a HIT earn 1.0 each, opposers the inverse — this feeds the scoreboard weights. supported: Brad Gerstner, Chamath, Friedberg, Jason, Sacks

Conviction timeline

bands: green ≥ 65 · watch ≥ 45 · ember ≥ 15

Plays vs SPY · % since first mention (2023-01-27)

Plays

expressionsymbolkindrelevancerationale
▼ SHORT PFEstock PRIMARY Pfizer is the named target of the Bourla/Rebel News confrontation and the biggest COVID-vaccine revenue line
▼ SHORT BNTXstock adjacent BioNTech shares the Pfizer mRNA franchise economics
▼ SHORT MRNAstock adjacent pure-play mRNA vaccine revenue and the vaccine specifically cited in the 30x myocarditis signal

Mention log

Sacks
Sacks equities w=0.89 · n=96 · E113 (2023-01-27) · explicit_prediction · strength 3 ▶ 1:00:39 SUPPORT
“one of the costs of this policy is going to be that people will stop trusting vaccination in general”
Friedberg
Friedberg equities w=0.87 · n=120 · E113 (2023-01-27) · explicit_prediction · strength 2 ▶ 59:02 SUPPORT
“You know, you start to question. I think we will start to see people question whether those are appropriate.”
Chamath
Chamath equities w=0.84 · n=160 · E113 (2023-01-27) · sentiment · strength 2 ▶ 54:05 SUPPORT
“because of all this, it probably is reasonable to take a step back and have a commission that just uncovers all of this stuff”
Jason
Jason equities w=0.97 · n=105 · E113 (2023-01-27) · sentiment · strength 1 ▶ 1:10:52 SUPPORT
“I'm not getting boosted again, no.”
Sacks
Sacks equities w=0.89 · n=96 · E126 (2023-04-28) · sentiment · strength 2 ▶ 1:13:16 SUPPORT
“Now, I don't know if he was right about those vaccines, but I do know that he's right in the case of COVID. They had an incentive to push this dubious mRNA shot on us so that we get boosted a zillion times.”
Chamath
Chamath equities w=0.84 · n=160 · E134 (2023-06-24) · explicit_prediction · strength 3 ▶ 56:45 SUPPORT
“But we ran something through and we allowed it to be labeled a word that misappropriates what it is. It's not a vaccine. And the problem with that is that it now makes people mistrust the measles, mumps and rubella vaccine. That's crazy. You shouldn't mistrust the MMR vaccine or DTaP. But because those things are lumped in with the same thing as a Covid vaccine that is at best 30 or 40 percent efficacious, we have these problems.”
Sacks
Sacks equities w=0.89 · n=96 · E134 (2023-06-24) · sentiment · strength 2 ▶ 1:02:55 SUPPORT
“We were injected with an experimental mRNA treatment because we got hoodwinked by the media into thinking it would prevent us from ever getting Covid, which it did not do. Two months later, I got Delta variant.”
Brad Gerstner
Brad Gerstner (regular guest ×1.0) equities w=0.95 · n=22 · E134 (2023-06-24) · sentiment · strength 2 ▶ 1:00:03 SUPPORT
“Why can't we have an authentic postmortem about the efficacy of the Covid vaccine without being shamed?”
Sacks
Sacks equities w=0.89 · n=96 · E159 (2023-12-29) · sentiment · strength 2 ▶ 50:20 SUPPORT
“The reason why they are off so much is because of a massive drop in demand for PaxLavit and for COVID boosters. Apparently, people do not see the value in those products. ... I would say that the company is also suffering from a credibility crisis by not leveling with the public about the efficacy and safety of their vaccines.”

Who built this conviction

each voice's total force on the score — supports and opposes from every mention, weighted exactly as the replay applied them · share = % of all mention-driven movement

Sacks
Sacks w=0.89
4 scoring events · 55% of moves
+59.6 → net +59.6
Chamath
Chamath w=0.84
2 scoring events · 19% of moves
+21.0 → net +21.0
Brad Gerstner
Brad Gerstner w=0.95 regular guest ×1.0
1 scoring event · 10% of moves
+11.1 → net +11.1
Friedberg
Friedberg w=0.87
1 scoring event · 9% of moves
+9.9 → net +9.9
Jason
Jason w=0.97
1 scoring event · 7% of moves
+7.2 → net +7.2

⏳ decay drained -75.6 over the idea's life — that's time passing, attributed to no one

Score events

episodekindΔafternote
E113 2023-01-27 init +37.2 37.2 E113 born by Sacks (explicit_prediction x3) [w=0.89]
E113 2023-01-27 reinforce +11.8 49.0 E113 Chamath support x2 (new voice) [w=0.84]
E113 2023-01-27 reinforce +9.9 59.0 E113 Friedberg support x2 (new voice) [w=0.87]
E113 2023-01-27 reinforce +7.2 66.1 E113 Jason support x1 (new voice) [w=0.97]
E114 2023-02-04 decay -2.6 63.5 E114 silent
E115 2023-02-11 decay -2.5 61.0 E115 silent
E116 2023-02-17 decay -2.4 58.5 E116 silent
E118 2023-03-03 decay -2.3 56.2 E118 silent
E119 2023-03-11 decay -2.2 53.9 E119 silent
E120 2023-03-17 decay -2.2 51.8 E120 silent
E121 2023-03-24 decay -2.1 49.7 E121 silent
E122 2023-03-31 decay -2.0 47.7 E122 silent
E123 2023-04-07 decay -1.9 45.8 E123 silent
E124 2023-04-14 decay -1.8 44.0 E124 silent
E125 2023-04-21 decay -1.8 42.2 E125 silent
E126 2023-04-28 reinforce +7.7 49.9 E126 Sacks support x2 [w=0.89]
E128 2023-05-12 decay -2.0 47.9 E128 silent
E129 2023-05-19 decay -1.9 46.0 E129 silent
E130 2023-05-26 decay -1.8 44.1 E130 silent
E131 2023-06-02 decay -1.8 42.4 E131 silent
E132 2023-06-10 decay -1.7 40.7 E132 silent
E133 2023-06-16 decay -1.6 39.0 E133 silent
E134 2023-06-24 reinforce +9.2 48.2 E134 Chamath support x3 [w=0.84]
E134 2023-06-24 reinforce +11.1 59.4 E134 Brad Gerstner support x2 (new voice) [w=0.95]
E134 2023-06-24 reinforce +5.4 64.8 E134 Sacks support x2 [w=0.89]
E135 2023-07-01 decay -2.6 62.2 E135 silent
E136 2023-07-09 decay -2.5 59.7 E136 silent
E137 2023-07-14 decay -2.4 57.3 E137 silent
E139 2023-07-27 decay -2.3 55.0 E139 silent
E140 2023-08-04 decay -2.2 52.8 E140 silent
E141 2023-08-11 decay -2.1 50.7 E141 silent
E142 2023-08-18 decay -2.0 48.7 E142 silent
E143 2023-08-25 decay -1.9 46.7 E143 silent
E144 2023-09-01 decay -1.9 44.8 E144 silent
E146 2023-09-22 decay -1.8 43.0 E146 silent
E147 2023-09-29 decay -1.7 41.3 E147 silent
E148 2023-10-07 decay -1.7 39.7 E148 silent
E149 2023-10-13 decay -1.6 38.1 E149 silent
E150 2023-10-20 decay -1.5 36.6 E150 silent
E151 2023-10-27 decay -1.5 35.1 E151 silent
E152 2023-11-03 decay -1.4 33.7 E152 silent
E156 2023-12-08 decay -1.3 32.3 E156 silent
E157 2023-12-16 decay -1.3 31.1 E157 silent
E158 2023-12-23 decay -1.2 29.8 E158 silent
E159 2023-12-29 reinforce +9.3 39.1 E159 Sacks support x2 [w=0.89]
E160 2024-01-06 decay -1.6 37.6 E160 silent
E161 2024-01-13 decay -1.5 36.1 E161 silent
E162 2024-01-19 decay -1.4 34.6 E162 silent
E163 2024-01-26 decay -1.4 33.2 E163 silent